Fedaiisf Federation of Italian Associations of Scientific Representatives of Drugs and Parapharmaceuticals

Astrazeneca: the new CEO Soriot arrives from Roche

Finanzaonline.com – 28.8.12/09:10 Astrazeneca has appointed Pascal Soriot, former financial director of Roche, as managing director of the group. Soriot, 53…

Leggi »

Balduzzi decree. Foresti (Assogenerici): "The law on patent protection is aberrant"

For the president of Assogenerici it is an "old trick" thought up by drug companies to postpone entry…

Leggi »

NATIONAL FEDERAISF

Leggi »

Medicines, the Enpa's appeal "Generics also for animals"

The Enpa takes the field in support of the campaign "promoted by the Tuscan PD – reads a note from the Protection Body…

Leggi »

Italy: default of the "Health Objective"

by Giuseppe Lembo 58 The first miracle of the spending review is the elimination of scientific drugs, tested by pharmacological research. In…

Leggi »

Open letter to Mr. Francesco Lupinacci

1 – On 21 August last, the website www.informatori.it published the letter sent by Colleague Ferrarini to the editorial…

Leggi »

Trentino. Doctors 24 hours a day: expenditure of 30 million

28 August 2012 The revolution in Trentino healthcare? It is possible, but not at no cost. The "health decree" of the Government...

Leggi »

Goodbye to the general practitioner. Minister Balduzzi speaks: a series of measures that will improve healthcare and the relationship with patients

General practitioners available 24 hours a day, an electronic health card for everyone, an end to "political" recruitment in hospitals and…

Leggi »

Spain: with co-payment, pharmaceutical costs are reduced by a quarter

August 27 (ANSAmed) - MADRID, AUGUST 27 - Pharmaceutical spending fell in Spain in July by 24%…

Leggi »

Balduzzi's "mini reform" is ready. Here is the text of the decree

Sarà un decreto legge di 27 articoli. All’interno intramoenia e riordino dell’assistenza territoriale. Ma anche non autosufficienza, farmaci e governo…

Leggi »